Rhythm Pharmaceuticals buy Guggenheim
Start price
06.08.25
/
50%
€77.50
Target price
06.08.26
€103.73
Performance (%)
25.81%
Price
14.01.26
€91.00
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 25.81%. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 4.118% | 4.118% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Guggenheim for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Guggenheim from $119.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Guggenheim for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€75.50
10.07.25
10.07.25
-
10.07.26
10.07.26
29.14%
14.01.26
14.01.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.40
21.10.24
21.10.24
€64.45
21.10.25
21.10.25
95.04%
22.10.25
22.10.25